IBIO123
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for IBIO123, covering 2023-05-01 to 2023-09-13. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness [Phase 1, Phase 2]